Display options
Share it on

Cardiol Res. 2012 Apr;3(2):80-86. doi: 10.4021/cr168w. Epub 2012 Mar 20.

The Effects of Lowering Uric Acid Levels Using Allopurinol on Components of Metabolic Syndrome.

Cardiology research

Esther J Heimbach, Rodney G Bowden, Jackson O Griggs, A Alexander Beaujean, Eva I Doyle, Robert D Doyle

Affiliations

  1. Baylor University, Waco, Texas, USA.
  2. Family Health Center, Waco, Texas, USA.

PMID: 28348676 PMCID: PMC5358145 DOI: 10.4021/cr168w

Abstract

BACKGROUND: Researchers have reported an independent direct relationship between lipid levels and hyperuricemia with MetS. The purpose of this study was to determine the relationship between serum uric acid levels and lipids among patients on allopurinol.

METHODS: A retrospective secondary data analysis was conducted on 66 adult patients from a family health clinic in Central Texas. Medical records used were recorded during a nine year period (2002 - 2010) ascertaining the relationship between uric acid and lipids.

RESULTS: Spearman correlations revealed a weak correlation between uric acid and total cholesterol, a weak correlation between uric acid and triglycerides and LDL-C. A weak inverse correlation was discovered between uric acid and HDL-C. A moderate correlation was discovered when all lipid variables combined were compared to uric acid.

CONCLUSIONS: We discovered LDL-C and triglycerides to be significant predictors of uric acid with weak correlations. Additionally, weak correlations existed between uric acid and total cholesterol and HDL-C with an inverse relationship discovered with HDL-C. These findings support the literature suggesting that uric acid is more likely to be associated with total cholesterol and triglycerides. In addition, new discoveries serve as an indication that LDL-C may also be associated with uric acids levels. The mechanism by which uric acid may regulate lipids is elusive but suggestions have included suppression of lipid peroxidase and decreases in critical lipase activity.

Keywords: Cholesterol; Gout; HDL; Hyperuricemia; LDL

References

  1. Hypertension. 2000 Mar;35(3):746-51 - PubMed
  2. Diabet Med. 2006 May;23(5):469-80 - PubMed
  3. Brain. 2010 Mar;133(Pt 3):671-89 - PubMed
  4. Diabetes Care. 2004 Oct;27(10):2444-9 - PubMed
  5. Natl Health Stat Report. 2009 May 5;(13):1-7 - PubMed
  6. J Zhejiang Univ Sci B. 2007 Aug;8(8):593-8 - PubMed
  7. Am J Med. 2007 May;120(5):442-7 - PubMed
  8. Circ J. 2005 Aug;69(8):928-33 - PubMed
  9. Ann Rheum Dis. 1998 Sep;57(9):509-10 - PubMed
  10. Circulation. 2002 Dec 17;106(25):3143-421 - PubMed
  11. Heart. 2002 Mar;87(3):229-34 - PubMed
  12. BMC Musculoskelet Disord. 2011 May 20;12:103 - PubMed
  13. Am J Kidney Dis. 2006 Nov;48(5):761-71 - PubMed
  14. Circulation. 2005 Nov 15;112(20):3066-72 - PubMed
  15. J Clin Endocrinol Metab. 2003 Jun;88(6):2869-79 - PubMed
  16. ScientificWorldJournal. 2003 Oct 05;3:930-6 - PubMed
  17. Int J Obes (Lond). 2010 Mar;34(3):454-61 - PubMed
  18. Metabolism. 2007 Jun;56(6):751-6 - PubMed
  19. BMC Public Health. 2004 Mar 25;4:9 - PubMed
  20. Am J Physiol Renal Physiol. 2006 Mar;290(3):F625-31 - PubMed
  21. Eur J Endocrinol. 2009 Jan;160(1):45-52 - PubMed
  22. Circulation. 2004 Sep 7;110(10):1245-50 - PubMed
  23. Int Urol Nephrol. 2007;39(4):1227-33 - PubMed
  24. Acta Reumatol Port. 2010 Oct-Dec;35(5):466-74 - PubMed
  25. Eur J Epidemiol. 2007;22(7):439-45 - PubMed
  26. J Nephrol. 2007 Mar-Apr;20(2):212-8 - PubMed
  27. Anadolu Kardiyol Derg. 2009 Oct;9(5):385-9 - PubMed
  28. Nephrol Nurs J. 2010 Mar-Apr;37(2):133-41, 148; quiz 142 - PubMed
  29. Arterioscler Thromb Vasc Biol. 2005 May;25(5):1038-44 - PubMed

Publication Types